1. Chronic ingestion of caffeine by male NIH strain mice alters the density of a variety of central receptors.
INTRODUCTION
Chronic caffeine can cause tolerance in animals and humans, and subsequent abstinence from caffeine can then lead to withdrawal syndromes. The underlying mechanisms are poorly understood (Nehlig et al., 1992; Daly, 1993) . Blockade of central adenosine receptors resulting in an up-regulation of adenosine receptors has received attention as one explanation of the chronic effects of caffeine. Chronic treatment with caffeine does result in an apparent up-regulation of A1 adenosine receptors in rodents (Fredholm, 1982; Boulenger et al., 1983; Wu and Coffin, 1984; Green and Stiles, 1986; Zielke and Zielke, 1987; Hawkins et al., 1988; Ramkumar et al., 1988; Daval et al., 1989; Rudolphi et al., 1989 ; see also references in Nehlig et al., 1992; Daly, 1993) , and an enhanced sensitivity to behavioral effects of adenosine analogs (Ahlijanian et al., 1986; Nikodijevi6 et al., 1993) . The effects of chronic caffeine on other central receptors has received less attention. /~-Adrenergic receptors appear down-regulated, while ol-adrenergic receptors appear unchanged (Goldberg et al., 1982; Green and Stiles, 1986) . Caffeine does alter turnover of not only norepinephrine, but also of dopamine and serotonin (Berkowitz et al., 1970; Berkowitz and Spector, 1971; Corrodi et al., 1972; Hadfield and Milio, 1989) . The effects of chronic caffeine on levels of dopamine and serotonin receptors do not appear to have been assessed. Similarly, while behavioral effects of cholinergic agonists and antagonists are altered after chronic caffeine (Nikodijevi6 et al., 1992) , changes in muscarinic and nicotinic receptors have not been assessed. The density of benzodiazepine sites associated with GABAA-receptors appear increased after chronic caffeine (Wu and Coffin, 1984; Wu and Phillis, 1986) .
The effect of chronic ingestion of caffeine on a variety of central receptors and on calcium channels has now been probed using radioligand binding assays with male NIH-Swiss strain mice. The results provide evidence for significant alterations in adenosine, adrenergic, serotonergic, cholinergic and GABAergic systems. Such changes may underlie the changes in behavioral responses of such mice seen after chronic caffeine (Nikodijevi6 et al., 1993) .
METHODS

Materials
[3H] CGS21680 (specific activity, 47. 
Chronic Caffeine Administration
White male mice of the NIH Swiss strain, weight 25-30 g, were divided into two groups. The control group was given free access to water and food, while the chronic caffeine group was given access to water containing 0.1% caffeine for 4 days and to food. Caffeine ingestion was continued up to two to four hours before sacrifice. Based on water consumption, mice ingested -100 mg/kg of caffeine per day. For further details and behavioral studies with such mice see Nikodijevi6 et al. (1992) .
Membrane Preparation
The mice were killed by cervical fracture and the brains rapidly removed into ice-cold 50 mM Tris-HC1 buffer (pH 7.4). Cerebral cortex (5 mice), cerebellum (4 mice) or striatum (10 mice) were dissected from mice of either control or caffeine groups. Tissue was homogenized in 3 ml of ice-cold 50mM Tris-HCl buffer (pH 7.4), using a polytron at setting number 6 for 10 seconds. The homogenate was adjusted in volume to 7 ml using ice-cold 50 mM Tris-HC1 (pH 7.4) and centrifuged at 35000 × g for 15 min at 4°C. The pellet was suspended with polytron and recentrifuged in the same volume of buffer. The final pellet was resuspended in the appropriate incubation buffer at protein concentration of 2 3 mg/ml. Aliquots were used immediately for receptor-binding assays. Protein concentrations were determined by the BCA protein assay reagents (Pierce Chemical Co., Rockford, IL) using bovine albumin as standard.
[3H]N6-Cyclohexyladenosine (CHA) Binding
[3H]CHA binding to cortical membranes was measured by a modification of the method of Bruns et al. (1980) . The final pellet had been resuspended in 50raM Tris-HCl buffer (pH7.4), containing 8/ug/ml adenosine deaminase. Incubations were in the same buffer containing 100/~1 membrane suspension and [3H]CHA from 0.5 16 nM. The final volume was 1 ml. Each assay (90 min, 25°C) was performed in triplicate. Nonspecific binding was defined in the presence of 10/uM 2-chloroadenosine and was ca. 5% of the total binding. Binding reactions were terminated by filtration through Whatman GF/B filters using a Brandel M24R Cell Harvester (Brandel, Gaithersburg, MD). Filters were washed two times with 5 ml ice-cold buffer and placed in scintillation vials with 5 ml of Hydrofluor scintillation fluid, followed by counting for tritium.
[3H]CGS 21680 Binding
[3H]CGS 21680 binding to striatal membranes was measured by a modification of the method of Jarvis et al. (1989) . The final pellet had been resuspended in 50 mM Tris-HC1 (pH 7.4) buffer containing 8/~g/ml adenosine deaminase and 10 mM MgCI2. Incubations were in the same buffer containing 100/zl membrane suspension and [3H]CGS 21680 from 0.5-16 nM. The final volume was i ml. Each assay (90 min, 25°C) was performed in triplicate. Nonspecific binding was defined in the presence of 30/~M N6-R-phenylisopropyladenosine and was ca. 20% of the total binding. Filtration, washing and scintillation spectroscopy were as described for [3H]CHA.
[3H]Prazosin Binding [3H] Prazosin binding to cortical membranes was measured by a modification of the method of Glossman and Hornung (1980) . The final pellet had been suspended in 50 mM Tris HCI buffer (pH 7.4). Incubations were in the same buffer, containing 100/d membrane suspension and [3H]prazosin from 0.05-0.8 nM. The final volume was 1 ml. Each assay (30 min, 25 °) was performed in triplicate. Nonspecific binding was defined in the presence of 1/zM phentolamine and was ca. 10% of the total binding. Filtration, washing and scintillation spectroscopy were as described for [3H]CHA.
[3H]Clonidine Binding
[3H]Clonidine binding to cortical membranes was measured by a modification of the method described by U'Prichard et al. (1977) . The final pellet had been resuspended in 50 mM Tris HCI buffer (pH 7.4). Incubations were in the same buffer containing 100/zl membrane suspension and [3H]clonidine from 0.25 16 nM. The final volume was 1 ml. Each assay (30 min, 25°C) was performed in triplicate. Nonspecific binding was defined in the presence of 10/~M clonidine and was ca. 10% of the total binding. Filtration, washing and scintillation spectroscopy were as described for [3H]CHA.
[3H]Dihydroalprenolol (DHA) Binding
[3H]DHA binding to cortical membranes for E1 adrenergic receptors and to cerebellum membranes for ~2 adrenergic receptors was measured by a modification of the method of Bylund and Snyder (1976) . The final pellet had been resuspended in 50 mM Tris HCI buffer (pH 7.4), containing 10 mM MgClz and 1 mM EDTA. Incubations were in the same buffer containing 100 #1 membrane suspension and [3H]DHA from 0.125-8 nM. The final volume was i ml. Each assay (30 min, 30°C) was performed in triplicate. Nonspecific binding was defined in the presence of 10/zM propranolol and was ca. 30% of total binding. Filtration, washing and scintillation spectroscopy were as described for [3H]CHA.
[3H]SCH 23390 Binding
[3H]SCH 23390 binding to the D1 dopaminergic receptor in striatal membranes was measured essentially as described (Ferretti, et al., 1992) . The final pellet had been resuspended in 50mM Tris HC1 buffer (pH7.4), containing 120mM NaCI, 5 mM KC1, 2 mM CaC12, and 1 mM MgCI2. Incubations were in the same buffer containing 100/~1 membrane suspension and [3H]SCH 23390 from 0.05-3.2nM. The final volume was l ml. Each assay (30min, 37°C) was performed in triplicate. Nonspecific binding was defined in the presence of 10/~M butaclamol and was ca. 5% of total binding. Filtration, washing and scintillation spectroscopy were as described for [3H]CHA.
[3H]Spiperone Binding
[3H]Spiperone binding to D2-dopaminergic receptors in striatal membranes was measured essentially as described (Michaluk et al., 1982) . The final pellet had been resuspended in 50 mM Tris HC1 buffer (pH 7.4), containing 120 mM NaCI, 5 mM KC1, 2 mM CaCI2, 1 mM MgC12, 10/~M pargyline, and 0.1% ascorbic acid. Incubations were in the same buffer containing 100/~1 membrane suspension and [3H]spiperone from 0.05-3.2 nM. Each assay (25 min, 37°C) was performed in triplicate. Nonspecific binding was defined in the presence of 1/~M butaclamol and was ca. 10% of the total binding. Filtration, washing and scintillation spectroscopy were as described for [3H]CHA.
[3H]Nicotine Binding
[3H]Nicotine binding to cortical membranes was measured by a modification of described procedures (Martino Garrows and Kellar, 1986; Marks et al., 1986) . The final pellet had been resuspended in 20mM Hepes buffer (pH7.4), containing 1 mM MgCI2, 120 nM NaC1, 5 mM KCI, and 2 mM CaCI2. Incubations were in the same buffer containing 100~tl membrane suspension, 200/~M diisopropyl-fluorophosphate and [3H]nicotine from 0.125-8.0nM. The final volume was l ml. Each assay (120min, 0-4°C) was performed in triplicate. Nonspecific binding was defined in the presence of 1/~M nicotine and was ca. 20% of total binding. Filtration, washing and scintillation spectroscopy were as described for [3H]CHA. The filters were presoaked in cold 0.3% polyethylenimine to reduce nonspecific binding.
[3HI Quinuclidinylbenzilate (QNB)
[3H]QNB binding to muscarinic receptors in cortical membranes was measured as follows: (see Yamamura and Snyder, 1979; Hammer et al., 1980) . The final pellet had been resuspended in 20mM Hepes buffer (pH7.4), containing 100 mM NaCI and 10 mM MgCI 2. Incubations were in the same buffer containing 100/tl membrane suspension and [3H]QNB from 0.05-0.8nM. The final volume was 1 ml. Each assay (30 min, 37°C) was performed in triplicate. Nonspecific binding was defined in the presence of 1 ~M atropine and was ca. 25% of the total binding. Filtration, washing and scintillation spectroscopy were as described for [3H]CHA. The filters were presoaked in 0.3% polyethylenimine to reduce nonspecific binding to filter.
[3H]Diazepam Binding
[3H]Diazepam binding to benzodiazepine sites on GABAA receptors in cortical membranes was measured essentially as described (Wu and Coffin, 1984) . The final pellet had been resuspended in 50mM Tris-HCl buffer (pH7.4). Incubations were in the same buffer containing 100/ul membrane suspension and [3H]diazepam from 0.5-16 nM. The final volume was i ml. Each assay (60 min, 0 4°C) was performed in triplicate. Nonspecific binding was defined in the presence of 20/uM Ro15-1788 and was ca. 10% of the total binding. Filtration, washing and scintillation spectroscopy were as described for [3H]CHA.
[aHl5-Hydroxytryptamine Binding [3H] 5-Hydroxytryptamine binding to 5-HT1 receptors in cortical membranes was measured by a modification of the method described by Pedigo et al. (1981) . The final pellet had been resuspended in 50mM Tris-HCl buffer (pH7.4), containing 4 mM CaCl2. Incubations were in the same buffer containing 10 #M pargyline, 100/ul membrane suspension and 3[H]5 hydroxytryptamine from 0.5-16 nM. The final volume was i ml. Each assay (10 min, 37°C) was performed in triplicate. Nonspecific binding was defined in the presence of 10/uM 5 hydroxytryptamine and was ca. 30% of the total binding. Filtration, washing and scintillation spectroscopy were as described for [3H]CHA.
[3H]Ketanserin Binding [3H]Ketanserin binding to 5 HT2 receptors in cortical membranes was measured by a modification of the method described by Leysen et al. (1986) . The final pellet had been resuspended in 50 mM Tris-HC1 buffer (pH 7.4). Incubations were in the same buffer, containing 100/~1 membrane suspension and 3[H]ketanserin from 0.25 8 nM. The final volume was 1 ml. Each assay (15 min, 37°C) was performed in triplicate. Nonspecific binding was defined in the presence of 1 ~M methysergide and was ca. 20% of the total binding. Filtration, washing and scintillation spectroscopy were as described for [3H]CHA.
[aH]MK-801 Binding
[3H]MK-801 binding to sites on NMDA receptors in cortical membranes was measured by a modification of the method described by Wong et al. (1986) . The final pellet had been resuspended in 5 mM Tris-HC1 buffer (pH 7.4). Incubations were in the same buffer, containing 100/~1 membrane suspension and [3H]MK 801 from 0.5-16nM. The final volume was l ml. Each assay (45min, 23°C) was performed in triplicate. Nonspecific binding was defined in the presence of 100/uM MK-801 and was ca. 5% of the total binding. Filtration, washing and scintillation spectroscopy were as described for [3H]CHA.
[3HlNitrendipine Binding
[3H]Nitrendipine binding to cortical membranes was measured by a modification of the method of Ehlert et al. (1982) . The final pellet had been resuspended in 50 mM Tris-HC1 buffer (pH 7.4). Incubations were in the same buffer, containing 100#I membrane suspension and [3H]nitrendipine from 0.05-1 nM. The final volume was 1 ml. Each assay (90 min, 25°C) was performed in the dark in triplicate. Nonspecific binding was defined in the presence of 1/~M nifedipine and was ca. 10% of total binding. Filtration, washing and scintillation spectroscopy were as described for [3H]CHA.
Data Analysis
The dissociation constant (KD) and the maximal number of binding sites (Bmax) were analyzed with the computer program LIGAND (Munson and Rodbard, 1980) for each experiment and for pooled data from at least three experiments and are reported as means + SEM. The statistical evaluations were performed with the Student's t-test.
RESULTS
Chronic ingestion of caffeine for a period of 4 days by male NIH Swiss strain mice results in significant changes in densities of a variety of cortical or cerebellar receptors and in density of cortical nitrendipine binding sites, presumed to be associated with L-type voltage sensitive calcium channels (Table I) 
DISCUSSION
The increase in density of cortical A1 adenosine receptors after chronic blockade of such receptors by caffeine (Table 1) is not unexpected. Indeed, such increases have been previously reported by many laboratories primarily for rats (see INTRODUCTION). One report of no change in Al-adenosine receptors in rat cerebral cortex after chronic caffeine has appeared (Holtzman et al., 1991) . In contrast to the up-regulation of A~-adenosine receptors, there was no increase in density of striatal A2A-adenosine receptors after chronic blockade of such receptors by caffeine (Table 1) . One study had reported no increase in striatal A2A-adenosine receptors as measured by autoradiography (Lupica et al., 1991) , while another study reported a slight increase as measured by membrane binding assays (Hawkins et al., 1988) . In vitro in striatal slices A~, but not AeA-adenosine receptors undergo desensitization (Abbracchio et al., 1992) . In contrast, in vivo in rats an adenosine analog, NECA, down-regulated striatal A2A adenosine receptors, while having no effect on A~ adenosine receptors .
The increase in m I adenosine receptors in male NIH Swiss strain mice (Table 1) is accompanied by an increase in sensitivity to the depressant effects of adenosine analogs on open-field locomotor activity (Nikodijevi6 et al., 1992) . Remarkably, this applies to both A1 and Aa selective analogs. There are synergistic effects on locomotor activity of A1 and A2 selective agonists (Nikodijevi6 et al., 1991) and thus endogenous adenosine through the A1 receptors could enhance behavioral effects of Ae selective adenosine analogs in control and chronic caffeine treated mice. It should be noted that male NIH Swiss strain mice do not become tolerant to the stimulatory effects of caffeine after chronic caffeine-ingestion (Nikodijevi6 et al., 1993) .
Caffeine is not known to block extracellular receptors other than adenosine receptors at the dosage level (-100 mg/kg/day) employed in the present study. Thus, effects of chronic caffeine on levels of other central receptors are likely indirect. Certainly, blockade by chronic caffeine of the tonic input of endogeneous adenosine to presynaptic receptors that are inhibitory to neurotransmitter release (Williams, 1987) would be expected to alter turnover and hence postsynaptic activation of receptors for a variety of central neurotransmitters, including norepinephrine, dopamine, serotonin, acetylcholine, y-aminobutyric acid and glutamate. Homeostatic regulation in such receptors or the second messenger systems subserved by such receptors might then be expected. The present results indicate that densities of some, but not all of such possible neurotransmitter receptors do significantly change as a result of 4 days of chronic caffeine ingestion (-100 mg/kg/day) in male NIH Swiss strain mice.
The reduction on density of both/61 and ]~2 adrenergic receptors in cerebral cortex and cerebellum, respectively (Table 1) , suggests a caffeine induced increase in turnover and action of norepinephrine at such receptors. Caffeine has been reported to increase norepinephrine turnover (Berkowitz et al., 1970; Corrodi et al., 1972; Hadfield and Milio, 1989) . A down-regulation of cortical fll adrenergic receptors has been previously reported for rats after chronic caffeine (Goldberg et al., 1982; Green and Stiles, 1986) or theophylline (Fredholm et al. 1984) . The lack of change in 0:1 and o:2 adrenergic receptors after chronic caffeine ingestion ( Table 1 ) suggests either that these receptors exist mainly at sites or pathways whose noradrenergic input is unaffected by caffeine or that such receptors are not under homeostatic control in this strain of mice. In rat brain the densities of 0:1 and o:2 adrenergic receptors were unaltered after chronic caffeine (Goldberg et aL, 1982) . A single injection of pentoxifylline (3, 7-dimethyl-l-(5-oxohexyl)xanthine) caused a decrease in densities of both o:2 and fll adrenergic receptors in cortex of rats (Lowenstein et aL, 1982) .
The lack of effect of chronic caffeine ingestion on dopamine receptors (Table 1) is remarkable in view of many reports, indicating a close interrelationship of adenosine and dopamine systems in striatum (see review by Ferr6 et al., 1992) . Thus, blockade of striatal adenosine receptors by caffeine enhances dopaminergic function (cf. Josselyn and Beninger, 1991 and references therein) . Conversely, chronic central infusion of adenosine analogs in rats causes an attentuation in both A2A adenosine and D 1 dopamine receptor elicited stimulation of striatal adenylate cyclase . Other treatments, such as dopamine receptor blockade or denervation, do result in alterations in sensitivity to dopaminergic agonists (Yarbrough 1975; Siggins et aL, 1984; Chipkin et al., 1984) . Behaviorally, chronic ingestion of caffeine in the male NIH Swiss strain mice has no significant effect on stimulation of locomotor activity elicited by amphetamine, but does increase the maximal percent stimulation elicited by cocaine (Nikodijevi6 et al., 1993) , agents thought to act by increasing dopaminergic function.
The densities of cortical 5HT1 and 5HT2-serotonin receptors are increased after chronic caffeine ingestion of male NIH Swiss strain mice (Table 1) , suggesting a reduction in serotonergic input and a resultant up regulation of receptors. However, caffeine has been reported in some studies to increase rather than decrease serotonin turnover in rats (Berkowitz and Spector, 1971; Corrodi et al., 1972) and mice (ValzeUi et al., 1973) . Thus, a down regulation of serotonin receptors might have been expected. Behaviorally, effects of serotonergic agents do not appear to have been investigated after chronic caffeine.
The densities of cholinergic receptors, both nicotinic and muscarinic, appear increased after chronic caffeine ingestion, suggesting a decrease in acetylcholine function and a resultant up regulation of receptors. However, chronic treatment of rats with nicotine increases the density of nicotinic receptors (Ksir et al., 1985; Hillard and Pound, 1993) . Thus, caffeine might be increasing nicotinic receptors by enhancing acetylcholine release, rather than by decreasing release. Acute caffeine does increase acetylcholine release from rat cerebral cortex (Phillis et al., 1980) . Behaviorally, it appears that muscarinic function is enhanced in NIH Swiss strain mice after chronic caffeine ingestion, since higher doses of a muscarinic antagonist, scopolamine, are required to stimulate openfield locomotor activity compared to control mice (Nikodijevi6 et al., 1993) . Both nicotinic (nicotine) and muscarinic (oxotremorine) agonists reduce openfield locomotor activity in control NIH Swiss strain mice, while being ineffective (nicotine) or less effective (oxotremorine) after chronic caffeine (Nikodijevi6 et al., 1993) . This too could be interpreted as due to increase in cholinergic function, so that any further depressant effects of nicotine or oxotremorine are blunted. The mice do exhibit a marked long term reduction in openfield locomotor activity after chronic caffeine (Nikodijevi6 et al., 1993) , which might reflect enhanced function of the up-regulated cholinergic receptors. Further studies directed towards such hypotheses are required. Chronic caffeine has been reported to reduce the excitatory effects of acetylcholine on rat cerebral cortical neurons (Lin and Phillis, 1990) . Chronic nicotine results in tolerance to depressant effects of nicotine in spite of up regulation of nicotinic receptors (Ksir et al., 1985) .
The density of GABAA receptors, as assessed by binding of the GABAA modulator diazepam, is increased markedly in NIH strain mice (Table 1) . There also appears to be a small but significant decrease in the affinity of diazepam; the nature of this decrease requires further investigation. Such an increase suggests an up-regulation of GABA n channels as a result of a decrease in GABAergic function during chronic caffeine treatment. An up regulation of benzodiazepine sites after chronic caffeine has been previously reported for rats (Wu and Coffin, 1984; Wu and Phillis, 1986) . Chronic caffeine at a low dose of 10 mg/kg/day has little effect on diazepam-elicited changes in glucose utilization in brains of rat (Nehlig et al., 1987) . Chronic theophylline does decrease the convulsant activity of various agents in rats (Szot et al., 1987) , but whether this is due to up-regulation of adenosine receptors or an up regulation of GABAA receptors or both is unknown.
The density of the NMDA class of glutamate receptors, as assessed by binding of the NMDA-channel blocker MK-1801, appears unchanged after chronic caffeine (Table 1) . This is perhaps surprising in view of reports of functional interrelationships of NMDA and adenosine receptors (Bartrup and Stone, 1990; Nagaoka et al., 1993) .
The density of L-type calcium channels, as assessed by binding of the L-type calcium channel antagonist nitrendipine is significantly increased in cortical membranes in male NIH Swiss strain mice after chronic caffeine ingestion (Table  1 ). The mechanism is unknown. Nitrendipine binding is also reported to be increased after chronic ethanol (Dolin et al., 1987) . Behavioral effects of calcium channel agents after chronic caffeine do not appear to have been assessed.
In summary, chronic ingestion of caffeine in male NIH Swiss strain mice results in increases in densities of A1, but not A2A adenosine receptors commensurate at least for the A1 receptors with direct chronic blockade of such receptors by caffeine. Other G protein linked receptors also show changes in densities, probably due to indirect effects of the blockade of adenosine receptors by caffeine on the tonic input of neurotransmitters to such G protein linked receptors. The fil and f12 adrenergic receptors are down-regulated, while 5HT~ and 5HT2 serotonin receptors and muscarinic receptors are up-regulated, c~1 and tr2 Adrenergic receptors and D1 and D2 dopaminergic receptors are unaffected.
Receptors that are part of a receptor-ion channel complex are also affected by chronic caffeine ingestion. The densities of the nicotinic receptor-channel and the GABAA receptor channel are increased, while the NMDA receptor channel appears unchanged. The density of L-type calcium channels, as assessed by nitrendipine binding is increased by chronic caffeine ingestion. In rats, the density of forskolin-binding sites, presumably associated with adenylate cyclase, is increased after chronic caffeine (Daval et al., 1989 ). It appears likely that most alterations in receptors, ion channels and effector systems after chronic caffeine will prove related to blockade of tonic adenosine input by caffeine, rather than to blockade of phosphodiesterases or release of calcium from intracellular sites, since the latter two effects become significant only at much higher concentrations that the expected 10 ~tM brain concentrations of caffeine attained during chronic ingestion of caffeine (100 mg/kg/day) (see Ahlijanian and Takemori, 1986) . It should be noted that phosphodiesterase inhibitors, including xanthines much more potent than caffeine do cause down-regulation of fl-adrenergic receptors (Lowenstein et al., 1982; Schultz and Schmidt, 1986) . Further studies on behavioral responses of caffeine treated NIH Swiss strain mice (cf. Nikodijevi6 et al., 1993) will be required to correlate changes in receptors and ion channels with caffeine induced tolerance, alteration in drug responsiveness, and withdrawal.
